Search by Drug Name or NDC
NDC 00187-0004-02 Siliq 210 mg/1 Details
Siliq 210 mg/1
Siliq is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch Health US LLC. The primary component is BRODALUMAB.
MedlinePlus Drug Summary
Brodalumab injection is used to treat moderate to severe plaque psoriasis (skin disease in which red, scaly patches form on some areas of the body) in people whose psoriasis is too severe to be treated by topical medications alone and who have not been treated successfully with other medications. Brodalumab injection is in a class of medications called monoclonal antibodies. It works by blocking the action of a certain natural substance in the body that causes the symptoms of psoriasis.
Related Packages: 00187-0004-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Brodalumab Injection
Product Information
NDC | 00187-0004 |
---|---|
Product ID | 0187-0004_044e3e17-7930-63ae-e063-6294a90acb9b |
Associated GPIs | 9025052000E520 |
GCN Sequence Number | 077139 |
GCN Sequence Number Description | brodalumab SYRINGE 210 MG/1.5 SUBCUT |
HIC3 | L1A |
HIC3 Description | ANTIPSORIATIC AGENTS,SYSTEMIC |
GCN | 43055 |
HICL Sequence Number | 044102 |
HICL Sequence Number Description | BRODALUMAB |
Brand/Generic | Brand |
Proprietary Name | Siliq |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Brodalumab |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION |
Route | SUBCUTANEOUS |
Active Ingredient Strength | 210 |
Active Ingredient Units | mg/1 |
Substance Name | BRODALUMAB |
Labeler Name | Bausch Health US LLC |
Pharmaceutical Class | Antibodies, Monoclonal [CS], Interleukin 17 Receptor A Antagonists [MoA], Interleukin-17 Receptor A Antagonist [EPC] |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA761032 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00187-0004-02 (00187000402)
NDC Package Code | 0187-0004-02 |
---|---|
Billing NDC | 00187000402 |
Package | 2 SYRINGE in 1 CARTON (0187-0004-02) / 1 INJECTION in 1 SYRINGE (0187-0004-00) |
Marketing Start Date | 2017-02-15 |
NDC Exclude Flag | N |
Pricing Information | N/A |